Full-Time

NPI Operations Project Manager

Posted on 12/20/2024

ENOVIS

ENOVIS

1,001-5,000 employees

Develops orthopedic and reconstructive medical devices

Healthcare

Mid, Senior

No H1B Sponsorship

Austin, TX, USA

Category
Project Management
Business & Strategy

You match the following ENOVIS's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PMP Certification
  • B.S degree in Project Management or Engineering
  • Minimum of 3 years of experience
Responsibilities
  • Develops, evaluate, revises and tracks project plans to identify and negotiate resolution of issues.
  • Escalate as necessary to management in order to ensure projects tasks are completed to the project timeline.
  • Develop supporting documents; supply plans, tracking spreadsheets, task lists and timelines to document or publish project requirements in order to monitor and track progress.
  • Develops and implements project communication methods and plans.
  • Attend and participate in cross functional project teams to provide updates and status to project requirements and timelines.
  • Collaborate with Product Development and Operations team members to identify, mitigate and resolve risks.
  • Attend and participate in meetings with product suppliers to monitor or address delivery status to product plan.
Desired Qualifications
  • Preferred experience in a regulated manufacturing environment

Enovis develops medical technology solutions aimed at improving patient outcomes and restoring mobility. The company operates in two main segments: Prevention & Recovery, which offers orthopedic solutions like bracing products and therapy systems for rehabilitation and sports medicine, and Reconstructive, which focuses on implant products for various joints and minimally invasive surgical tools. Enovis's products, including well-known brands like DonJoy and Aircast, are designed to address specific medical needs such as pain management and bone growth stimulation. What sets Enovis apart from competitors is its commitment to continuous improvement through the Enovis Growth Excellence (EGX) system, which enhances operations and customer satisfaction. The company's goal is to innovate in the medical technology field to create better outcomes for patients and healthcare providers globally.

Company Size

1,001-5,000

Company Stage

IPO

Total Funding

N/A

Headquarters

Wilmington, Delaware

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive surgical solutions boosts Enovis's market potential.
  • Integration of digital health technologies opens new avenues for product innovation.
  • LimaCorporate acquisition expands Enovis's market share in the European orthopedic sector.

What critics are saying

  • Increased competition from Stryker and Zimmer Biomet in the orthopedic market.
  • Potential supply chain complexities from integrating LimaCorporate operations.
  • Regulatory challenges in obtaining FDA approvals for new products.

What makes ENOVIS unique

  • Enovis offers a diverse portfolio of orthopedic and reconstructive solutions.
  • The company integrates advanced materials like vitamin E-doped polyethylene in implants.
  • Enovis's acquisition of LimaCorporate enhances its transatlantic business capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Legal Services

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

30%

2 year growth

2%
Global Tech Times
Sep 9th, 2024
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Enovis appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies.

MarketBeat
Jan 3rd, 2025
Confluence Investment Management LLC Makes New $3.49 Million Investment in Enovis Co. (NYSE:ENOV)

Confluence Investment Management LLC makes new $3.49 million investment in Enovis Co. (NYSE:ENOV).

Plastics Today
Aug 20th, 2024
PE With Vitamin E Booster Improves Longevity of Medical Implant

Medtech company Enovis Corp. has unveiled its Scandinavian Total Ankle Replacement (STAR Ankle) upgrade, which is reportedly the first FDA-cleared mobile bearing ankle system with a polyethylene (PE) insert doped with vitamin E.

MarketBeat
Nov 27th, 2024
Dynamic Technology Lab Private Ltd Makes New $1.05 Million Investment in Enovis Co. (NYSE:ENOV)

Dynamic Technology Lab Private Ltd makes new $1.05 million investment in Enovis Co. (NYSE:ENOV).

The Manila Times
Jan 6th, 2025
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Enovis to participate in the 43rd Annual J.P. Morgan Healthcare Conference.

Chattanooga Rehabilitation Center
Aug 14th, 2024
Beyond Insurance: Why Rehabilitation Clinicians Are Embracing Cash-Pay Services

Recognizing this important shift, Enovis(TM) has created a comprehensive eBook to help clinicians navigate the world of cash-pay services.

Defense World
May 3rd, 2024
GAMMA Investing LLC Makes New Investment in Enovis Co. (NYSE:ENOV)

GAMMA Investing LLC makes new investment in Enovis Co. (NYSE:ENOV).

TipRanks
Aug 19th, 2024
Enovis introduces STAR Ankle, with e+ Polyethylene

Enovis introduces STAR Ankle, with e+ Polyethylene.

MassDevice
Jan 17th, 2025
Enovis appoints new president of International Surgical business

Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical business.

ADCBUS
Sep 10th, 2024
How Should Investors React To Colfax Corporation's (NYSE:CFX) CEO Pay?

Matt Trerotola became the CEO of Colfax Corporation (

TipRanks
Aug 20th, 2024
Enovis expands EMPOWR Revision Knee system to include EMPOWR Cones

Enovis announced the expansion of its EMPOWR Revision Knee system to include EMPOWR Cones.

INACTIVE